These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29328435)

  • 21. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
    Okamura S; Yoshino H; Kuroshima K; Tsuruda M; Osako Y; Sakaguchi T; Yonemori M; Yamada Y; Tatarano S; Nakagawa M; Enokida H
    BMC Cancer; 2021 Jan; 21(1):48. PubMed ID: 33430801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer.
    Wang H; Zhang W; Zuo Y; Ding M; Ke C; Yan R; Zhan H; Liu J; Wang J
    Tumour Biol; 2015 Dec; 36(12):9631-40. PubMed ID: 26150338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
    Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
    J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.
    Zhu Y; Liang S; Pan H; Cheng Z; Rui X
    J Biosci; 2018 Jun; 43(2):365-373. PubMed ID: 29872024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer.
    Li Y; Zu X; Hu X; Wang L; He W
    Med Sci Monit; 2019 Nov; 25():8928-8939. PubMed ID: 31761897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10.
    Liu F; Lou K; Zhao X; Zhang J; Chen W; Qian Y; Zhao Y; Zhu Y; Zhang Y
    Int J Mol Med; 2018 Dec; 42(6):3027-3036. PubMed ID: 30272290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ursolic acid induces apoptosis via Akt/NF-κB signaling suppression in T24 human bladder cancer cells.
    Gai L; Cai N; Wang L; Xu X; Kong X
    Mol Med Rep; 2013 May; 7(5):1673-7. PubMed ID: 23483134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA‑214 promotes proliferation and inhibits apoptosis via targeting Bax in nasopharyngeal carcinoma cells.
    He J; Tang Y; Tian Y
    Mol Med Rep; 2015 Oct; 12(4):6286-92. PubMed ID: 26239171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
    Wang J; Zhao X; Shi J; Pan Y; Chen Q; Leng P; Wang Y
    Oncol Rep; 2016 Oct; 36(4):2049-58. PubMed ID: 27571748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of HAX-1 induced by miR-325 resensitizes bladder cancer cells to cisplatin-induced apoptosis.
    Li R; Zheng JZ; Huang X
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9303-9314. PubMed ID: 33015771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-497 upregulation inhibits cell invasion and metastasis in T24 and BIU-87 bladder cancer cells.
    Wei Z; Hu X; Liu J; Zhu W; Zhan X; Sun S
    Mol Med Rep; 2017 Aug; 16(2):2055-2060. PubMed ID: 28656286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin.
    Dukaew N; Chairatvit K; Pitchakarn P; Imsumran A; Karinchai J; Tuntiwechapikul W; Wongnoppavich A
    Oncol Rep; 2020 Oct; 44(4):1441-1454. PubMed ID: 32945500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells.
    Zeng LP; Hu ZM; Li K; Xia K
    J Cell Mol Med; 2016 Mar; 20(3):559-67. PubMed ID: 26800397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.
    Ma J; Huang H; Han Z; Zhu C; Yue B
    Biomed Res Int; 2015; 2015():147468. PubMed ID: 26229955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells.
    Shahjee HM; Koch KR; Guo L; Zhang CO; Keay SK
    J Exp Clin Cancer Res; 2010 Dec; 29(1):160. PubMed ID: 21143984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA‑214 targets Wnt3a to suppress liver cancer cell proliferation.
    Yang Y; Zhao Z; Hou N; Li Y; Wang X; Wu F; Sun R; Han J; Sun H; Song T; Huang C; Shao Y
    Mol Med Rep; 2017 Nov; 16(5):6920-6927. PubMed ID: 28901526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR‑485‑5p inhibits bladder cancer metastasis by targeting HMGA2.
    Chen Z; Li Q; Wang S; Zhang J
    Int J Mol Med; 2015 Oct; 36(4):1136-42. PubMed ID: 26239806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
    Wang G; Fang X; Han M; Wang X; Huang Q
    Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.